Haruo Sugiyama

机构：Osaka University of Economics, Osaka City University, The University of Osaka · ORCID：0000-0002-0844-2175

发表论文 380 篇 · 总被引 12833 次 · h-index 56

代表论文

• WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome (2025 · Journal of Hematology & Oncology · 被引 30)
• Dendritic cells pulsed with multifunctional Wilms’ tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 24)
• Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors (2024 · PLoS ONE · 被引 5)
• Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report (2024 · Journal of Medical Case Reports · 被引 4)
• Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor (2024 · Cancer Immunology Immunotherapy · 被引 3)
• Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy (2024 · Scientific Reports · 被引 3)